Wird geladen...

Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group

Background: There is ample evidence of important symptomatic efficacy of tumour necrosis factor α (TNFα) inhibition in ankylosing spondylitis (AS). Moreover, studies suggest that anti-TNF could be considered as the first disease controlling antirheumatic treatment (DC-ART) for AS. Objective: To dete...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pham, T, van der Heijde, D, Calin, A, Khan, M, van der Linden, S., Bellamy, N, Dougados, M
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2003
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1754653/
https://ncbi.nlm.nih.gov/pubmed/12922951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.62.9.812
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!